Literature DB >> 19430893

Radiologic follow-up of non-functioning pituitary adenomas: rationale and cost effectiveness.

Ian C Coulter1, Nitin Mukerji, Nicholas Bradey, Vincent Connolly, Philip J Kane.   

Abstract

Patients with non-functioning pituitary adenomas (NFPAs) are followed-up with serial endocrine, ophthalmologic and radiological assessment. There is a lack of evidence based guidance regarding the frequency and duration of radiological assessment during follow-up. We retrospectively analysed the details of follow-up radiological scanning in a cohort of patients diagnosed with NFPAs in an attempt to devise a rational and cost effective scanning schedule for use in routine clinical practice. 49 patients were identified using the hospital endocrine register. A detailed review of the case notes and follow up scans was undertaken. The data was analysed using descriptive statistics and Kaplan-Meier survival analysis using SPSS ver 13.0 (SPSS Inc. Chicago, IL). The time in which the tumor size in the followed up patients reached a state of 'no change' which persisted for at least two further scans was calculated. 41 patients, followed up for a median duration of 70 months were ultimately analysed. 33 patients had surgery while eight were conservatively managed. The time taken by 50% of tumors to achieve a steady state of 'no change' in tumor size on scans was 30 months. 90% of tumours achieved this state in 88 months. Surgical management did not significantly influence the time required to attain the steady state on a Kaplan-Meier analysis (Log rank test P = 0.06). NFPAs need extended follow-up since late recurrences after treatment are known. Routine radiologic follow up may be uneconomical after the steady state is achieved. Regular Goldmann perimetry beyond this time may be of greater use in selecting patients who actually need repeat surgical debulking. This method of follow up is likely to be more cost effective and reduce the number of scans performed.

Entities:  

Mesh:

Year:  2009        PMID: 19430893     DOI: 10.1007/s11060-009-9901-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Gamma Knife radiosurgery for pituitary adenomas.

Authors:  M Hayashi; M Izawa; H Hiyama; S Nakamura; S Atsuchi; H Sato; K Nakaya; K Sasaki; T Ochiai; O Kubo; T Hori; K Takakura
Journal:  Stereotact Funct Neurosurg       Date:  1999       Impact factor: 1.875

2.  Surgical management of pituitary adenomas.

Authors:  J A Jane; E R Laws
Journal:  Singapore Med J       Date:  2002-06       Impact factor: 1.858

3.  Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function analysis.

Authors:  P W Grigsby; J R Simpson; B Fineberg
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

4.  Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas.

Authors:  K O Lillehei; D L Kirschman; B K Kleinschmidt-DeMasters; E C Ridgway
Journal:  Neurosurgery       Date:  1998-09       Impact factor: 4.654

5.  Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study.

Authors:  J Feldkamp; R Santen; E Harms; A Aulich; U Mödder; W A Scherbaum
Journal:  Clin Endocrinol (Oxf)       Date:  1999-07       Impact factor: 3.478

Review 6.  Clinically non-functioning pituitary adenoma.

Authors:  Craig A Jaffe
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

7.  MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas.

Authors:  Gustavo Soto-Ares; Christine Cortet-Rudelli; Richard Assaker; Arnaud Boulinguez; C Dubest; Didier Dewailly; Jean Pierre Pruvo
Journal:  Eur J Endocrinol       Date:  2002-02       Impact factor: 6.664

8.  Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

Authors:  T Lohmann; C Trantakis; M Biesold; S Prothmann; S Guenzel; R Schober; R Paschke
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

9.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

10.  Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results.

Authors:  I Ciric; M Mikhael; T Stafford; L Lawson; R Garces
Journal:  J Neurosurg       Date:  1983-09       Impact factor: 5.115

View more
  1 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.